Progress in passive immunization for the prevention of infant respiratory syncytial virus infection

VernacularTitle:婴幼儿呼吸道合胞病毒感染被动免疫制剂应用进展
Author: Weijun HU ¹ ; Ruize WANG ; Shaobai ZHANG
Author Information

1. 陕西省疾病预防控制中心免疫规划所，西安　710054
Publication Type:Journal Article
Keywords: Respiratory syncytial virus; Infant; Passive immune prophylaxis
From: Chinese Journal of Preventive Medicine 2025;59(10):1787-1794
CountryChina
Language:Chinese
Abstract: Respiratory syncytial virus (RSV) is a common pathogen that causes acute respiratory infections, especially in infants and young children. There are currently no RSV-specific antiviral drugs, and there are no approved vaccines for infants and young children. With the widespread use of RSV passive immunizations in infants and young children in 2022 and the effective reduction of the burden of RSV infection-related diseases, passive immune-prophylaxis of RSV infection has attracted more and more attention. This paper summarizes the implementation experience and real-world application effect of passive immune-prophylaxis for RSV infection at home and abroad, to provide reference for the immune-prophylaxis practice of passive immune-prophylaxis for RSV infection in infants and young children in China.